Mortality in rheumatoid arthritis: have we made an impact in 4 decades?
The excess mortality associated with RA has not changed in 4 decades. Moreover, people with RA have not enjoyed the same improvements in survival experienced by their non-RA peers. More attention should be paid to mortality as an outcome measure in RA.
The incremental costs of using different IV PPI regimens are modest compared with total per patient costs.